Google News – FDA (biotech/pharma) External News
Life Sciences & Pharma Articles
Google News – EMA (biotech/pharma) External News
Atossa Therapeutics (ATOS) Gains 4.6%: Biotech Stock Tests Key Resistance - Triple EMA - vinanet.vn
Google News – Oncology External News
GSK’s first lung cancer approval, a new IPO path and more - Fierce Pharma
Google News – FDA (biotech/pharma) External News
The FDA was all in on AI. Will that change? - Pharma Voice
Google News – FDA (biotech/pharma) External News
Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback - Fierce Pharma
Google News – EMA (biotech/pharma) External News
July 2026 EMA/CHMP medicines recommended for approval - The Pharma Letter
Google News – Clinical Trials External News
Digital Health Technologies (DHTs) for Drug Development - fda.gov
Google News – Oncology External News
Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference - Business Wire
Google News – FDA (biotech/pharma) External News
What’s in the FDA’s latest batch of rejection letters - Pharma Voice
Google News – Biopharma External News
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts - BioSpace
Google News – FDA (biotech/pharma) External News
FDA panel endorses broader use of certain peptides - BioPharma Dive
Google News – Pharmaceuticals External News
Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia - Arrowhead Pharmaceuticals, Inc.
Industry News External News
Trump's generic drugs tariff threatens Indian pharma's top market - Nikkei Asia
Google News – Oncology External News
Bayer, Kairos Pharma Collaborate to Boost Xofigo Effectiveness in Metastatic Prostate Cancer - Contract Pharma
Google News – FDA (biotech/pharma) External News